FIELD: pharmaceutics.
SUBSTANCE: invention relates to boron-containing compounds, namely to the compound which represents 5-fluoro-1,3-dihydro-1-hydroxy-3-methyl-2,1-benzoxaborole, 6-fluoro-1-hydroxy-1,2,3,4-tetrahydro-2,1-benzoxaborine, 5-cyano-1,3-dihydro-1-hydroxy-2,1-benzoxaborole, 1,3-dihydro-1-hydroxy-5-methyl-2,1-benzoxaborole, 1,3-dihydro-1-hydroxy-5-hydroxymethyl-2,1-benzoxaborole, 7-hydroxy-2,1-oxaborolano[5,4-cl]pyridine, 3-benzyl-1,3-dihydro-1-hydroxy-3-methyl-2,1-benzoxaborole, 3-benzyl-1,3-dihydro-1-hydroxy-2,1-benzoxaborole, 6-phenoxy-1,3-dihydro-1-hydroxy-2,1-benzoxaborole, 5-(N-methyl-N-phenyl sulfanilamide)-1,3-dihydro-1-hydroxy-2,1-benzoxaborole, 6-(4-methoxyphenyl sulfonyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaborole, 6-(4- methoxyphenyl sulfonyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaborole or 4-(4-cyano-phenoxy)-1,3-dihydro-1-hydroxy-2,1-benzoxaborole or its pharmaceutically acceptable salt. Invention also discloses the compound and its pharmaceutically acceptable salt of formula (IIb), pharmaceutical compositions, use of compounds and pharmaceutical compositions.
EFFECT: invention enables to obtain compounds applicable for treating or preventing infection.
84 cl, 12 dwg, 6 tbl, 20 ex
Title | Year | Author | Number |
---|---|---|---|
BORON-CONTAINING SMALL MOLLECULES | 2006 |
|
RU2414906C2 |
BORON-BASED SMALL MOLECULES AS ANTI-INFLAMMATORY DRUGS | 2007 |
|
RU2508113C2 |
BORON-CONTAINING SMALL MOLECULES AS ANTI-INFLAMMATORY AGENTS | 2007 |
|
RU2642628C2 |
BORON-CONTAINING SMALL MOLECULES AS ANTI-INFLAMMATORY AGENTS | 2009 |
|
RU2547441C2 |
PYRIDINES SUBSTITUTED WITH HETEROARYL AND APPLICATION METHODS | 2017 |
|
RU2756743C2 |
HETEROCYCLIC COMPOUNDS AND METHODS OF THEIR USE | 2012 |
|
RU2648997C2 |
AGONIST OF THE GLUCOCORTICOID RECEPTOR AND ITS IMMUNOCONJUGATES | 2017 |
|
RU2745748C2 |
ACTIVE COMPOUNDS WITH RESPECT TO BROMO-DOMAINS | 2015 |
|
RU2743074C2 |
SUBSTITUTED 1,2-DIHYDRO-3H-PYRAZOLO[3,4-D]PYRIMIDIN-3-ONES | 2019 |
|
RU2812726C2 |
SUBSTITUTED CHROMANS | 2015 |
|
RU2718060C2 |
Authors
Dates
2017-01-10—Published
2006-02-16—Filed